en · de · es · pt
sr9009-notes.peptides9002.com › News › Regulation, Testing, And Storage — Beginner to Advanced

Regulation, Testing, And Storage — Beginner to Advanced

By Editorial Desk · published 2026-07-04 · last reviewed 2026-07-28 · News

This is a working overview of HPLC-MS, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-07-28. Anything still debated is marked as such rather than presented as settled.

Regulation, Testing, and Storage

SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.

Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.

Background and Mechanism of SR9009

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

Sr9009 at a glance

PropertyValueNotes
Regulatory statusNot approved as a medicine in major jurisdictionsSold as a research chemical; legal status varies
Anti-doping statusProhibited by the World Anti-Doping AgencyListed under non-approved substances or related category
Typical analytical methodLC-MS/MSUsed for detection and confirmation in biological samples
Storage temperature−20 °C or lower for solidDesiccated and protected from light
Common solution solventsDMSO; ethanolAqueous solubility is limited

Handling Storage and Quality Control

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Related pages on this site

Analytical and Handling Considerations

Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.

SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.

For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.

Background and Receptor Pharmacology

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.

Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.

Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

Reference notes

Mathematicians believe that it may lead to advances in science and technology. Astronomers confirm that Jupiter's Great Red Spot is wobbling and fluctuating in size after observing its time-lapse video made from the images captured by the Hubble Space Telescope between December 2023 to March 2024. An experimental study introduces a new cognitive fallacy, the "illusion of information adequacy". It suggests many "assume that the cross-section of relevant information to which they are privy is sufficient to adequately understand the situation" to be able to form a reasonable conclusion, opinion, or decision. The Nobel Prize in Chemistry 2024 was divided, one half awarded to David Baker "for computational protein design", the other half jointly to Demis Hassabis and John M. Jumper "for protein structure prediction" 10 October – Scientists use a high-level machine learning model "SHBoost", to process data and estimate precise stellar properties for 217 million stars observed by the Gaia mission. 11 October – Astronomers observe the "inside-out" growth of NGC 1549 by using the James Webb Space Telescope. Researchers assume that it could solve the mystery of how these complex structures are being formed from gas clouds. 12 October – The long-period comet C/2023 A3 (Tsuchinshan–ATLAS) makes its closest approach to Earth. 13 October – SpaceX achieves the first successful return and capture of a Super Heavy booster from Starship, the biggest and most powerful rocket ever to fly.

== Controversial terminology == A toxic heavy metal is a common but misleading term for a metal-like element noted for its potential toxicity. Not all heavy metals are toxic and some toxic metals are not heavy. The International Union of Pure and Applied Chemistry (IUPAC), which standardizes nomenclature, says the term "'heavy metals' is both meaningless and misleading". The IUPAC report focuses on the legal and toxicological implications of describing "heavy metals" as toxins when there is no scientific evidence to support a connection. The density implied by the adjective "heavy" has almost no biological consequences, and pure metals are rarely the biologically active substance. This characterization has been echoed by numerous reviews. The most widely used toxicology textbook, Casarett and Doull's Toxicology, uses "toxic metal", not "heavy metals". Nevertheless many scientific and science-related articles, including medical texts, continue to use "heavy metal" as a term for toxic substances.

=== Latin America and Caribbean === Gustavo Petro, President of Colombia, initially suggested that any attack on Venezuela would equate to an attack on Latin America and the Caribbean, and thus Colombia's armed forces could support Venezuela; he later moderated his position. On 23 September, he addressed the UN General Assembly to call for a "criminal process" to be opened against Donald Trump for US strikes in the Caribbean. Colombia convened an extraordinary virtual meeting of the Community of Latin American and Caribbean States in September 2025, which concluded with an expression of "deep concern" over foreign intervention in the region. Over Guatemala's objection that procedures were not followed, the group issued a statement saying the region must remain a "Zone of Peace" based on "... the prohibition of the threat or use of force, the peaceful settlement of disputes, the promotion of dialogue and multilateralism, unrestricted respect for sovereignty and territorial integrity, non-interference in the internal affairs of States, and the inalienable right of peoples to self-determination." Guatemala's president Bernardo Arévalo said Guatemala was included in the list of 21 countries (of the 33 members) approving the text, although it did not sign, nor did Ecuador, Peru, Costa Rica, and El Salvador. In August, when the initial three ships were deployed, Prime Minister of Trinidad and Tobago Kamla Persad-Bissessar offered the US military access to her nation for the US to protect Guyana amid the Guyana–Venezuela crisis.

Sources: en.wikipedia.org

Notes from published material

=== Independent (1919-1967) === In 1919, physicist and university lecturer Frederick David Edwards and his father William founded their eponymous business in Camberwell, London, as Edwards Equipment and Services. They sold vacuum pumps to research laboratories from the UK, France, Germany and the USA. When World War II began, German patents were voided in the UK, which meant Edwards was cut off from their suppliers. This led the company to begin manufacturing its own products in 1939. The firm was rebranded W Edwards and Co in 1940, then Edwards High Vacuum International Ltd in 1950, and moved from London to Crawley in 1953. Edwards purchased Italian freeze-drying equipment manufacturer Alto Vuoto SpA in 1954, followed by the Shoreham factory of former subcontractor J H Holmes and Son Ltd in 1958. In the 1960s the firm listed as a public company and suffered from strike actions. Its founder FD Edwards died, and after financial difficulties, the company was sold to BOC.

== Results == The plebiscite took place on 11 July 1920, when Poland appeared on the verge of defeat in the Polish-Soviet War (see Miracle at the Vistula). The pro-German side was able to organise a very successful propaganda campaign by building on the long campaign of Germanisation; notably, the plebiscite asking the electorate to vote for Poland or East Prussia is said to have masked the pro-German choice under the provincial name of East Prussia. However, the weight of that argument can not have been strong because the voters were aware East Prussia was just a German province, not a sovereign state, as an alternative for Germany. The activity of pro-German organisations and the Allied support for the participation of those who were born in the plebiscite area but did not live there any longer helped the vote toward Germany. In the end, the weight of the evidently-substantial number of pro-German emigration voters can be ignored in the light of the 96% pro-German overall total. Anyway, the plebiscite resulted in a vast majority for East Prussia. Only a small part of the territory affected by the plebiscite was awarded to Poland, and most of it remained in Germany. Poland's supposed disadvantage by the Versailles Treaty stipulation was that it enabled those to return to vote if they were born in the plebiscite areas but no longer living there. Most of them were supposed to have been influenced by German national sentiments. For that reason, German nationalist societies and political parties wanted to assist them by facilitating their travel to the plebiscite area.

reverse genetics An experimental approach in molecular genetics in which a researcher starts with a known gene and attempts to determine its function or its effect on phenotype by any of a variety of laboratory techniques, commonly by deliberately mutating the gene's DNA sequence or by repressing or silencing its expression and then screening the mutant organisms for changes in phenotype. When the gene of interest is the only one in the genome whose expression has been manipulated, any observed phenotypic changes are assumed to be influenced by it. This is the opposite of forward genetics, in which a known phenotype is linked to one or more unknown genes.

where arg(x,y) is the clockwise angle between the X-axis and the vector (x,y); a function that is available in many programming languages as atan2(y,x). Conversely, given c and α, one can get the type (n,m) by the formulas:

Sources: en.wikipedia.org

Background from the literature

Overseas territories of European allies, including territories in Africa. "The general area of China" – Cambodia, Laos, Vietnam, Burma, and the Philippines. In the countries referred to as being in the general area of China, the Marshall Plan (ECA) operated through Special Technical and Economic Missions (STEMs). The STEMs were set up in 1950 and 1951, and had a "Point Four character" in the sense that they emphasized services by technical experts. Minimizing overlaps with the Marshall Plan, Point Four managed assistance mainly in:

Since its first application in 1967, directed evolution methodologies have been used to develop biomolecules with new properties and functions. Early examples include the modification of the bacteriophage Qbeta replication system and the generation of ribozymes with modified cleavage activity. In 1990, two teams independently developed and published SELEX (Systematic Evolution of Ligands by EXponential enrichment) methods and generated RNA aptamers: the lab of Larry Gold, using the term SELEX for their process of selecting RNA ligands against T4 DNA polymerase and the lab of Jack Szostak, selecting RNA ligands against various organic dyes. Two years later, the Szostak lab and Gilead Sciences, acting independently of one another, used in vitro selection schemes to generate DNA aptamers for organic dyes and human thrombin, respectively. In 2001, SELEX was automated by J. Colin Cox in the Ellington lab, reducing the duration of a weeks-long selection experiment to just three days. In 2002, two groups led by Ronald Breaker and Evgeny Nudler published the first definitive evidence for a riboswitch, a nucleic acid-based genetic regulatory element, the existence of which had previously been suspected. Riboswitches possess similar molecular recognition properties to aptamers. This discovery added support to the RNA World hypothesis, a postulated stage in time in the origin of life on Earth.

=== Secreted extracellular condensates === Secreted thyroglobulin colloid and colloid nodules of the thyroid gland Secreted casein 'micelles' of the mammary gland Serum albumin and globulins Secreted lysozyme

Sources: en.wikipedia.org

Frequently asked questions

Is SR9009 legal?

Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.

How is SR9009 detected?

Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.

How should SR9009 be stored?

Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.

What is SR9009?

SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.

Network